ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 999,78
-1,01%
DAX
17 932,17
-1,10%
Brent Oil
86,165
-1,28%
Bitcoin
60 397,17
-5,39%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. DermTech Inc (DMTK)

  7. DermTech Inc (DMTK) Actualités

DMTK DermTech Inc

0,6254
0,0304 (5,11%)
Dernière mise à jour : 19:13:57
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
DermTech Inc DMTK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0304 5,11% 0,6254 19:13:57
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,5773 0,572 0,64 0,595
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/4/202422:15BWDermTech to Explore Strategic Alternatives and Implement..
01/4/202422:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
08/3/202414:05BWDermTech Presents Research Abstracts at the 2024 American..
08/3/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:17EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:53EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:05EDGAR2Form 8-K - Current report
29/2/202422:01BWDermTech Reports Fourth-Quarter 2023 Financial Results
13/2/202414:05BWDermTech Announces Release Date for Fourth-quarter 2023..
31/1/202422:32EDGAR2Form 8-K - Current report
31/1/202422:30BWDermTech Announces Additional Restructuring Actions to Focus..
18/1/202414:05BWDermTech Announces Positive Topline Results From a Study..
16/1/202414:05BWDermTech Simplifies the DermTech Melanoma Test (DMT) by..
10/1/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:00BWDermTech Announces Positive Topline Results From Trust 2..
14/12/202322:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
12/12/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
21/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
07/11/202319:57PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
02/11/202321:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:09EDGAR2Form 8-K - Current report
02/11/202321:01BWDermTech Reports Third-Quarter 2023 Financial Results
31/10/202310:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
24/10/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/10/202314:05BWDermTech Announces Release Date for Third-Quarter 2023..
23/9/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202302:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/9/202322:05BWDermTech Grants New CCO Mark Aguillard Inducement Award..
19/9/202314:05BWDermTech Announces Contracts With Highmark for the..
13/9/202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202302:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202314:10EDGAR2Form 8-K - Current report
11/9/202314:05BWDermTech Appoints Mark Aguillard as Chief Commercial Officer
25/8/202314:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
12/8/202300:44EDGAR2Form 144 - Report of proposed sale of securities
07/8/202322:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/8/202322:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:07EDGAR2Form 8-K - Current report
03/8/202322:01BWDermTech Reports Second-Quarter 2023 Financial Results
19/7/202314:00BWDermTech Announces Favorable Coverage Policy With Blues Plan..
17/7/202314:00BWDermTech Announces Release Date for Second-Quarter 2023..
14/7/202302:17EDGAR2Form 144 - Report of proposed sale of securities
13/7/202322:09EDGAR2Form 8-K/A - Current report: [Amend]

Dernières Valeurs Consultées

NASDAQ
DMTK
DermTech
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés